Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMID 18174197)

Published in J Antimicrob Chemother on January 03, 2008

Authors

M Bassetti1, E Repetto, E Righi, S Boni, M Diverio, M P Molinari, M Mussap, S Artioli, F Ansaldi, P Durando, G Orengo, F Bobbio Pallavicini, C Viscoli

Author Affiliations

1: Infectious Disease Division, San Martino Hospital and University of Genoa School of Medicine, Genova, Italy. matteo.bassetti@hsanmartino.it

Articles citing this

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45

Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother (2009) 2.22

Colistin in the 21st century. Curr Opin Infect Dis (2009) 1.93

Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care (2011) 1.72

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.43

Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One (2012) 1.40

Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India (2012) 1.40

Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev (2010) 1.12

Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs (2014) 1.06

Colistin for lung infection: an update. J Intensive Care (2015) 1.03

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica (2013) 0.99

Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. Eur J Clin Microbiol Infect Dis (2014) 0.98

A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol (2014) 0.94

Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria. Ups J Med Sci (2014) 0.90

The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock. Virulence (2013) 0.89

Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. J Med Chem (2013) 0.87

Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (2013) 0.83

Tolerability and efficacy of long-term treatment with daptomycin, ceftazidime and colistin in a patient with a polymicrobial, multidrug-resistant prosthetic joint reinfection: a case report. J Med Case Rep (2014) 0.83

Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial. Trials (2015) 0.80

Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. J Res Pharm Pract (2015) 0.80

Multidrug-resistant Acinetobacter baumannii infection in children. BMJ Case Rep (2011) 0.78

Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection. Sci Rep (2015) 0.76

Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol (2017) 0.75

Evaluation of five susceptibility test methods for detection of tobramycin resistance in a cluster of epidemiologically related Acinetobacter baumannii isolates. J Clin Microbiol (2013) 0.75

Multiple lung abscesses due to acinetobacter infection: a case report. Cases J (2009) 0.75

Variables determining the development of colistin-associated renal impairment. Wien Klin Wochenschr (2015) 0.75

Articles by these authors

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet (2005) 4.17

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78

Neurofibromatosis type 1 growth charts. Am J Med Genet (1999) 2.32

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplant (1998) 1.87

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol (1997) 1.63

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant (2011) 1.56

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55

Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48

Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet (1995) 1.46

Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma. Horm Res (2005) 1.42

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41

Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet (1999) 1.40

Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit. J Chemother (2009) 1.39

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother (1995) 1.31

Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension. Eur J Clin Pharmacol (1986) 1.24

Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant (2009) 1.21

The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS (1997) 1.20

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother (1996) 1.19

Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen. J Clin Microbiol (2001) 1.17

Case definitions for human poisonings postulated to palytoxins exposure. Toxicon (2011) 1.17

Blood and breath analyses as biological indicators of exposure to trihalomethanes in indoor swimming pools. Sci Total Environ (1998) 1.16

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect (2011) 1.15

The role of sensory cues in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord (2000) 1.14

Successful treatment of Acremonium fungemia with voriconazole. Mycoses (2003) 1.14

Chloroform in alveolar air of individuals attending indoor swimming pools. Arch Environ Health (1993) 1.11

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant (2010) 1.11

Economic aspects of empiric antibiotic therapy for febrile neutropenia in children with cancer. Support Care Cancer (1998) 1.10

Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant (2015) 1.08

Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay. J Antimicrob Chemother (2012) 1.08

Effect of passive smoking during pregnancy on selected perinatal parameters. Int J Epidemiol (1990) 1.04

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group. Antimicrob Agents Chemother (1991) 1.03

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. Clin Vaccine Immunol (2007) 1.03

Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci (2014) 1.02

Galactomannan: testing the same sample twice? Transpl Infect Dis (2012) 1.02

Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol (1988) 1.01

Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: case reports with literature review. J Infect (1997) 1.01

Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol (1999) 1.01

Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. Eur J Ophthalmol (2005) 0.99

Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis (2000) 0.99

Indoor air quality in the university libraries of Modena (Italy). Sci Total Environ (1996) 0.99

Value of C reactive protein in the assessment of erosive osteoarthritis of the hand. Ann Rheum Dis (2005) 0.99

Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection (2011) 0.98

Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect (2014) 0.98

Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect (2010) 0.97

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect (2011) 0.97

New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples. J Chemother (2007) 0.97

Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and respiratory syncytial virus. J Prev Med Hyg (2006) 0.97

Measles outbreak in Grosseto, central Italy, 2006. Euro Surveill (2006) 0.96

Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients. J Hosp Infect (2009) 0.94

Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance. J Prev Med Hyg (2011) 0.94

MRSA carriage: the relationship between community and healthcare setting. A study in an Italian hospital. J Hosp Infect (2000) 0.94

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect (2012) 0.93

Antifungal prophylaxis with azole derivatives. Clin Microbiol Infect (2004) 0.93

Occupational exposure to trihalomethanes in indoor swimming pools. Sci Total Environ (2001) 0.92

Neck muscle vibration disrupts steering of locomotion. J Appl Physiol (1985) (2001) 0.92

Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res (2005) 0.92

C-reactive protein and serum amyloid A protein in neonatal infections. Scand J Infect Dis (2000) 0.92

Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy. Euro Surveill (2007) 0.92

Moderate maternal drinking and outcome of pregnancy. Eur J Epidemiol (1993) 0.92

Candidaemia in internal medicine departments: the burden of a rising problem. Clin Microbiol Infect (2013) 0.91

Environmental and biological monitoring of chloroform in indoor swimming pools. J Chromatogr A (1995) 0.91

Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology (Oxford) (2006) 0.91

A large outbreak of Opisthorchis felineus in Italy suggests that opisthorchiasis develops as a febrile eosinophilic syndrome with cholestasis rather than a hepatitis-like syndrome. Eur J Clin Microbiol Infect Dis (2011) 0.91

Antimicrobial use and resistance among Gram-negative bacilli in an Italian intensive care unit (ICU). J Chemother (2006) 0.91

Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer (2001) 0.91

Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol. Bone Marrow Transplant (1996) 0.91

An Italian consensus for invasive candidiasis management (ITALIC). Infection (2013) 0.90

Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients. J Int Med Res (2005) 0.90

Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy. J Int Med Res (2008) 0.90

Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients. Clin Vaccine Immunol (2011) 0.90

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis (2003) 0.89

Infections in the compromised child. Baillieres Clin Haematol (1991) 0.89

Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur Rev Med Pharmacol Sci (2014) 0.89

Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology (2009) 0.89

Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases. J Clin Oncol (1991) 0.89